Oral Mesalazine, Global Market Size Forecast, Top 5 Players Rank and Market Share | |
Oral Mesalazine Market Summary Oral Mesalazine refers to a formulation of mesalazine intended for oral administration. Mesalazine is a medication used in the treatment of inflammatory bowel diseases, and it is typically provided to patients in the form of oral tablets, capsules, or granules for ingestion. According to the new market research report "Global Oral Mesalazine Market Report 2023-2029", published by QYResearch, the global Oral Mesalazine market size is projected to reach USD 112 million by 2029, at a CAGR of 3.7% during the forecast period. According to QYResearch Top Players Research Center, the global key manufacturers of Oral Mesalazine include AbbVie, Shire, Salix Pharmaceuticals, Ferring Global, Teva Pharmaceutical Industries etc. | |
Target State: All States Target City : All Cities Last Update : 19 March 2024 1:11 PM Number of Views: 86 | Item Owner : Laura Contact Email: (None) Contact Phone: (None) |
Friendly reminder: Click here to read some tips. |